185 related articles for article (PubMed ID: 21334948)
1. Paradoxical exacerbation of tuberculosis after TNFα antagonist discontinuation: beware of immune reconstitution inflammatory syndrome.
Rivoisy C; Amrouche L; Carcelain G; Séréni D; Bourgarit A
Joint Bone Spine; 2011 May; 78(3):312-5. PubMed ID: 21334948
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical response to tuberculosis treatment in a patient receiving tumor necrosis factor-alpha antagonist.
Moureau C; Pothen L; Wilmes D; Yombi JC; Coche E; Hainaut P
Am J Med; 2012 Jun; 125(6):e9-e10. PubMed ID: 22502953
[No Abstract] [Full Text] [Related]
3. Central nervous system manifestations of tuberculosis-associated immune reconstitution inflammatory syndrome during adalimumab therapy: a case report and review of the literature.
Tanaka T; Sekine A; Tsunoda Y; Takoi H; Lin SY; Yatagai Y; Hayasihara K; Saito T
Intern Med; 2015; 54(7):847-51. PubMed ID: 25832955
[TBL] [Abstract][Full Text] [Related]
4. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
5. [Screening for tuberculosis infection prior to medical therapy].
Ravn P
Ugeskr Laeger; 2011 Mar; 173(12):893-6. PubMed ID: 21419060
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS.
Rivoisy C; Tubach F; Roy C; Nicolas N; Mariette X; Salmon D; Lortholary O; Bourgarit A;
Joint Bone Spine; 2016 Mar; 83(2):173-8. PubMed ID: 26677996
[TBL] [Abstract][Full Text] [Related]
7. A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.
Arend SM; Leyten EM; Franken WP; Huisman EM; van Dissel JT
Clin Infect Dis; 2007 Dec; 45(11):1470-5. PubMed ID: 17990230
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculous liver abscess, anti-TNF alpha, and immune reconstitution inflammatory syndrome].
Dussouillez G; Zayet S; Kone D; Royer PY; Toko-Tchuindzie L; Ruyer O; Gendrin V
Med Mal Infect; 2020 Feb; 50(1):90-91. PubMed ID: 31477453
[No Abstract] [Full Text] [Related]
9. Use of steroids to treat anti-tumor necrosis factor α induced tuberculosis-associated immune reconstitution inflammatory syndrome: Case report and literature review.
Nabeya D; Kinjo T; Yamaniha K; Yamazato S; Tome R; Miyagi K; Nakamura H; Kinjo T; Haranaga S; Higa F; Fujita J
Medicine (Baltimore); 2020 Oct; 99(43):e22076. PubMed ID: 33120729
[TBL] [Abstract][Full Text] [Related]
10. Extra-pulmonary Reactivation of Latent Tuberculosis After Initiation of Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease-Are Current Screening Strategies Adequate?
Tranah TH; Luk SY; Gess M
J Crohns Colitis; 2017 Jun; 11(6):762-763. PubMed ID: 27932451
[No Abstract] [Full Text] [Related]
11. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
[No Abstract] [Full Text] [Related]
12. Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapy.
Wendling D; Balblanc JC; Briançon D; Brousse A; Lohse A; Deprez P; Humbert P; Aubin F
Joint Bone Spine; 2008 May; 75(3):315-8. PubMed ID: 18329935
[TBL] [Abstract][Full Text] [Related]
13. Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases.
Yang JY; Jo KW; Hong S; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Park SH; Shim TS
Infect Dis (Lond); 2016 Apr; 48(4):293-298. PubMed ID: 26667845
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphoma.
Canaani J; Amit S; Ben-Ezra J; Cohen Pour M; Sarid N; Lerman H; Perry C; Polliack A; Naparstek E; Herishanu Y
J Clin Oncol; 2013 Apr; 31(11):e178-80. PubMed ID: 23439758
[No Abstract] [Full Text] [Related]
15. [Tuberculosis-associated immune reconstitution inflammatory syndrome].
Leone S; Nicastri E; Giglio S; Corpolongo A; Narciso P; Acone N
Infez Med; 2008 Dec; 16(4):193-9. PubMed ID: 19155683
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical Mycobacterium tuberculosis meningitis immune reconstitution inflammatory syndrome in an HIV-infected child.
Kalk E; Technau K; Hendson W; Coovadia A
Pediatr Infect Dis J; 2013 Feb; 32(2):157-62. PubMed ID: 22935867
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution inflammatory syndrome in central nervous system tuberculosis.
Manea E; Munteanu D; Jipa R; Moroti R; Arama V; Diaconu IA; Hristea A
Pneumologia; 2015; 64(4):32-6. PubMed ID: 27451593
[TBL] [Abstract][Full Text] [Related]
18. Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.
Efde MN; Houtman PM; Spoorenberg JP; Jansen TL
Neth J Med; 2005 Mar; 63(3):112-4. PubMed ID: 15813424
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.
Elliott JH; Vohith K; Saramony S; Savuth C; Dara C; Sarim C; Huffam S; Oelrichs R; Sophea P; Saphonn V; Kaldor J; Cooper DA; Chhi Vun M; French MA
J Infect Dis; 2009 Dec; 200(11):1736-45. PubMed ID: 19874177
[TBL] [Abstract][Full Text] [Related]
20. Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.
Sánchez-Moya AI; Dauden E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):730-3. PubMed ID: 21564322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
